United States· US:68071-2357_4b34f7e8-fb23-1311-e063-6294a90a3a1c
Phenazopyridine Hydrochloride
A phenazopyridine product containing phenazopyridine hydrochloride, registered in United States by NuCare Pharmaceuticals,Inc.. The same ATC class is registered in 2 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Phenazopyridine is registered in 2 of 19 countries.
Countries holding a registration under ATC G04BX06 (phenazopyridine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 1 of them publish a price we can compare per daily dose
Phenazopyridine · ATC G04BX06
2 / 19 countries
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PHENAZOPYRIDINE HYDROCHLORIDE
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Country
- United States (US)
- ATC code
- G04BX06
- ATC class
- Phenazopyridine
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc1168071-2357-2
- ndc1168071-2357-4
- ndc1168071-2357-8
- ndc11680712357212 TABLET in 1 BOTTLE (68071-2357-2)
- ndc1168071235744 TABLET in 1 BOTTLE (68071-2357-4)
- ndc1168071235788 TABLET in 1 BOTTLE (68071-2357-8)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
40 interactions on record for phenazopyridine.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Phenazopyridine · interactions on record
40 records
- 4 severe
- 36 moderate
Most severe, free to view
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- LeflunomideL04AK01severe
- TeriflunomideL04AK02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Phenazopyridine in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cd66efa6-3273-4485-91a8-f3b2bd0b846d GET /v1/drugs/cd66efa6-3273-4485-91a8-f3b2bd0b846d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "100",
"substance": "PHENAZOPYRIDINE HYDROCHLORIDE",
"productndc": "68071-2357",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG OTHER"
}See everything about phenazopyridine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.